IPP Bureau
Aster DM Healthcare signs Corporate TB Pledge
By IPP Bureau - October 15, 2022
Periodic community awareness program through Aster’s DM Healthcare’s visual media and social media platforms and implementing TB control activity through Aster Pharmacies across South India
BJ Wadia Children's Hospital and Cipla Foundation launches pediatric palliative home care services
By IPP Bureau - October 15, 2022
The hospital has taken a huge step by offering “Titli-palliative care services at home” to provide curative, restorative, and life-prolonging treatment to seriously ill children
ANDA approval from USFDA for Unichem's Extended Phenytoin Sodium Capsules
By IPP Bureau - October 15, 2022
Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures
DKSH acquires two ear care brands
By IPP Bureau - October 14, 2022
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.
JB Pharma publishes its maiden sustainability report
By IPP Bureau - October 14, 2022
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Roche Diagnostics and Apollo Hospitals puts spotlight on safe blood for transfusion
By IPP Bureau - October 14, 2022
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
Intuitive India unveils ‘Xi experience centre
By IPP Bureau - October 14, 2022
Xi Experience centre is aimed at familiarizing and bringing awareness about robotic-assisted surgery among the surgical fraternity in the country
Cytel to acquire SDS Life Science and SDS MedteQ
By IPP Bureau - October 14, 2022
The move will add new global talent to Cytel’s Strategic Consulting group
Prime Minister Modi to lay foundation stone of Bulk Drug Park in Una
By IPP Bureau - October 13, 2022
The Bulk Drug Park is expected to attract investment of around Rs. 10,000 crore and provide employment to more than 20,000 people
Celanese support the sustained-release drug delivery market
By IPP Bureau - October 13, 2022
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan
By IPP Bureau - October 13, 2022
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
Dupixent Phase 3 data showed significant histological remission of eosinophilic esophagitis
By IPP Bureau - October 13, 2022
68% of children on a higher dose of Dupixent achieved histological disease remission at week 16
Jacobio Pharma to collaborate with Merck on clinical trial of JAB-21822
By IPP Bureau - October 13, 2022
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.
Piramal Pharma Solutions launches ADCelerate
By IPP Bureau - October 13, 2022
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
M. Holland join hands with LyondellBasell to distribute purell medical grade resins
By IPP Bureau - October 13, 2022
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
